Literature DB >> 7876978

Protection of calves with a vaccine against Cryptosporidium parvum.

J A Harp1, J P Goff.   

Abstract

Cryptosporidium parvum causes enteric infection and diarrhea in calves, other species of economically important livestock, and humans. There are no effective treatments currently licensed for this parasite, and preventive measures are difficult. In addition to direct economic losses to the cattle industry, infected calves may contaminate water supplies with oocysts and contribute to human cryptosporidiosis. We have developed a vaccine offering partial protection against C. parvum infection in calves. Nine calves received an oral preparation of lyophilized C. parvum oocysts shortly after birth, and 10 calves served as nonvaccinated controls. All calves received colostrum. At 1 wk of age, all calves were administered 10(4) viable C. parvum oocysts orally. Clinical disease and oocyst shedding were monitored daily. Mean duration of diarrhea was 4 days for control calves and 1.7 days for vaccinated calves. Mean duration of oocyst shedding was 5.3 days for control calves and 2 days for vaccinated calves. These differences were statistically significant and suggest that this vaccine has the potential to reduce diarrhea and oocyst shedding caused by C. parvum.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876978

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  14 in total

1.  Obtaining hyperimmune anti-Cryptosporidium parvum ovine colostrum. A study of the humoral immune response in immunized sheep.

Authors:  S Martín-Gómez; M A Alvarez-Sánchez; F A Rojo-Vázquez
Journal:  Parasitol Res       Date:  2005-11-16       Impact factor: 2.289

2.  Randomly amplified polymorphic DNA PCR analysis of bovine Cryptosporidium parvum strains isolated from the watershed of the Red River of the North.

Authors:  K V Shianna; R Rytter; J G Spanier
Journal:  Appl Environ Microbiol       Date:  1998-06       Impact factor: 4.792

3.  Application of recombinant Cryptosporidium parvum P23 for isolation and prevention.

Authors:  Zahra Omidian; Elahe Ebrahimzadeh; Parisa Shahbazi; Zeinab Asghari; Parviz Shayan
Journal:  Parasitol Res       Date:  2013-10-24       Impact factor: 2.289

4.  Recombinant Cryptosporidium parvum p23 as a target for the detection of Cryptosporidium-specific antibody in calf sera.

Authors:  Parviz Shayan; Elahe Ebrahimzadeh; Mohamad-Reaza Mokhber-Dezfouli; Sadegh Rahbari
Journal:  Parasitol Res       Date:  2008-08-03       Impact factor: 2.289

5.  Efficacy of mangiferin against Cryptosporidium parvum in a neonatal mouse model.

Authors:  S Perrucci; G Fichi; C Buggiani; G Rossi; G Flamini
Journal:  Parasitol Res       Date:  2006-03-18       Impact factor: 2.289

6.  Antibody fusions reduce onset of experimental Cryptosporidium parvum infection in calves.

Authors:  Michael Imboden; Deborah A Schaefer; Robert D Bremel; E Jane Homan; Michael W Riggs
Journal:  Vet Parasitol       Date:  2012-03-06       Impact factor: 2.738

7.  Isolation of Small Number of Cryptosporidium parvum Oocyst Using Immunochromatography.

Authors:  Elahe Ebrahimzade; Parviz Shayan; Zeinab Asghari; Sedighe Jafari; Zahra Omidian
Journal:  Iran J Parasitol       Date:  2014 Oct-Dec       Impact factor: 1.012

Review 8.  Bovine cryptosporidiosis: impact, host-parasite interaction and control strategies.

Authors:  Sarah Thomson; Carly A Hamilton; Jayne C Hope; Frank Katzer; Neil A Mabbott; Liam J Morrison; Elisabeth A Innes
Journal:  Vet Res       Date:  2017-08-11       Impact factor: 3.683

Review 9.  Successful vaccines for naturally occurring protozoal diseases of animals should guide human vaccine research. A review of protozoal vaccines and their designs.

Authors:  Milton M McAllister
Journal:  Parasitology       Date:  2014-01-28       Impact factor: 3.234

Review 10.  Use of Veterinary Vaccines for Livestock as a Strategy to Control Foodborne Parasitic Diseases.

Authors:  Valeria A Sander; Edwin F Sánchez López; Luisa Mendoza Morales; Victor A Ramos Duarte; Mariana G Corigliano; Marina Clemente
Journal:  Front Cell Infect Microbiol       Date:  2020-06-26       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.